Preferred Name |
bivalirudin |
|
Synonyms |
Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu Phe-Pro-Arg-Pro-(Gly)4 desulfato-Tyr63'-hirugen Hirulog-1 Angiomax bivalirudin trifluoroacetate Phe-Pro-Arg-Pro-(Gly)4-desulfohirudin-(53-64) L-leucine, D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl- Angiomax RTU BG-8967 CTB-001 BG 8967 BG8967 Hirulog |
|
ID |
http://purl.bioontology.org/ontology/MESH/C074619 |
|
altLabel |
Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu Phe-Pro-Arg-Pro-(Gly)4 desulfato-Tyr63'-hirugen Hirulog-1 Angiomax bivalirudin trifluoroacetate Phe-Pro-Arg-Pro-(Gly)4-desulfohirudin-(53-64) L-leucine, D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl- Angiomax RTU BG-8967 CTB-001 BG 8967 BG8967 Hirulog |
|
cui |
C5227708 C0939677 C4684933 C0210057 C0210056 C0168273 C5690690 |
|
HM |
D010446 D011994 D006629 |
|
Inverse of RB |
TN9BEX005G 8631NP8608 0 |
|
isa | ||
LT |
TRD |
|
Mapped to |
http://purl.bioontology.org/ontology/MESH/D011994 |
|
MDA |
19920618 |
|
MeSH Frequency |
1297 |
|
MMR |
20220622 |
|
notation |
C074619 |
|
PA |
D000991 |
|
PI |
*RECOMBINANT PROTEINS (92) |
|
prefLabel |
bivalirudin |
|
RR |
8631NP8608 128270-60-0 (bivalirudin) |
|
SC |
1 |
|
Scope Statement |
designed to bind to the alpha-thrombin catalytic site and anion-binding exosite for fibrin(ogen) recognition |
|
SRC |
Biochem J 1992 May 1;283( Pt 3):737-43 |
|
TERMUI |
T231405 T001121333 T461332 T231406 T001121547 T001121548 T231403 T231408 T231407 T231402 T000967799 T231410 T231404 T231409 |
|
TH |
US FDA SRS (2017) NLM (2019) NLM (1992) NLM (2022) USAN (19XX) INN (19XX) |
|
tui |
T116 T129 T121 |